Taken together, these results suggest that chronic vglycin treatment ameliorates metabolic stress in middle-aged T2DM mice by improving glucose and insulin tolerance to control obesity and normalize plasma glucose, consistent with our previous findings in young T2DM Wistar rats. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.